We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
5ec9
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5ec9 is ON HOLD Authors: Leysen, S., Ottmann, C., Schafer, A., Scheepstra, M., Brunsveld, L., Sunden, R., Ma, J.N., Burnstein, E.S., Olsson, R. Des...) |
|||
| (5 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and a fragment of the coactivator TIF2== | |
| + | <StructureSection load='5ec9' size='340' side='right'caption='[[5ec9]], [[Resolution|resolution]] 2.30Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5ec9]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EC9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5EC9 FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.3Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5LO:4-[(11S,15R)-4,4,7,7-TETRAMETHYL-16-OXATETRACYCLO[8.6.0.03,8.011,15]HEXADECA-1(10),2,8-TRIEN-11-YL]BENZOIC+ACID'>5LO</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ec9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ec9 OCA], [https://pdbe.org/5ec9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ec9 RCSB], [https://www.ebi.ac.uk/pdbsum/5ec9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ec9 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/RXRA_HUMAN RXRA_HUMAN] Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.<ref>PMID:10195690</ref> <ref>PMID:11162439</ref> <ref>PMID:11915042</ref> <ref>PMID:20215566</ref> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | The nuclear receptor Nurr1 can be activated by RXR via heterodimerization (RXR-Nurr1) and is a promising target for treating neurodegenerative diseases. We herein report the enantioselective synthesis and SAR of sterically constricted benzofurans at RXR. The established SAR, using whole cell functional assays, lead to the full agonist 9a at RXR (pEC50 of 8.2) and RXR-Nurr1. The X-ray structure shows enantiomeric discrimination where 9a optimally addresses the ligand binding pocket of RXR. | ||
| - | + | Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.,Sunden H, Schafer A, Scheepstra M, Leysen S, Malo M, Ma JN, Burstein ES, Ottmann C, Brunsveld L, Olsson R J Med Chem. 2016 Feb 11;59(3):1232-8. doi: 10.1021/acs.jmedchem.5b01702. Epub, 2016 Jan 28. PMID:26820900<ref>PMID:26820900</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[ | + | </div> |
| - | [[Category: | + | <div class="pdbe-citations 5ec9" style="background-color:#fffaf0;"></div> |
| - | [[Category: | + | |
| - | [[Category: Brunsveld | + | ==See Also== |
| - | [[Category: Leysen | + | *[[Retinoid X receptor 3D structures|Retinoid X receptor 3D structures]] |
| - | [[Category: Olsson | + | == References == |
| - | [[Category: | + | <references/> |
| - | [[Category: | + | __TOC__ |
| - | [[Category: Scheepstra | + | </StructureSection> |
| - | [[Category: | + | [[Category: Homo sapiens]] |
| + | [[Category: Large Structures]] | ||
| + | [[Category: Brunsveld L]] | ||
| + | [[Category: Burnstein ES]] | ||
| + | [[Category: Leysen S]] | ||
| + | [[Category: Ma JN]] | ||
| + | [[Category: Olsson R]] | ||
| + | [[Category: Ottmann C]] | ||
| + | [[Category: Schafer A]] | ||
| + | [[Category: Scheepstra M]] | ||
| + | [[Category: Sunden R]] | ||
Current revision
Retinoic acid receptor alpha in complex with chiral dihydrobenzofuran benzoic acid 9a and a fragment of the coactivator TIF2
| |||||||||||
Categories: Homo sapiens | Large Structures | Brunsveld L | Burnstein ES | Leysen S | Ma JN | Olsson R | Ottmann C | Schafer A | Scheepstra M | Sunden R
